These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15353324

  • 21. Excessive myocardial calcinosis in a chronic hemodialyzed patient.
    Zazgornik J, Balcke P, Rokitansky A, Schmidt P, Kopsa H, Minar E, Graninger W.
    Klin Wochenschr; 1987 Jan 15; 65(2):97-100. PubMed ID: 3560789
    [Abstract] [Full Text] [Related]

  • 22. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.
    Deicher R, Ziai F, Bieglmayer C, Schillinger M, Hörl WH.
    J Am Soc Nephrol; 2005 Jun 15; 16(6):1811-8. PubMed ID: 15814831
    [Abstract] [Full Text] [Related]

  • 23. The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients.
    Ono K.
    Clin Nephrol; 1989 Jan 15; 31(1):31-4. PubMed ID: 2914408
    [Abstract] [Full Text] [Related]

  • 24. [Levels of serum ascorbate and its metabolites in hemodialysis patients].
    Hirano H, Tone Y, Otani H, Oya M, Kimura K, Saika Y, Fujii R, Mune M, Ichinose M, Yukawa S.
    Nihon Jinzo Gakkai Shi; 2004 Jul 15; 46(5):426-33. PubMed ID: 15446598
    [Abstract] [Full Text] [Related]

  • 25. Excretion of 4-pyridoxic acid and oxalic acid in patients with urinary calculi.
    Tiselius HG.
    Invest Urol; 1977 Jul 15; 15(1):5-8. PubMed ID: 873737
    [Abstract] [Full Text] [Related]

  • 26. Relation of serum ascorbic acid to serum vitamin B12, serum ferritin, and kidney stones in US adults.
    Simon JA, Hudes ES.
    Arch Intern Med; 1999 Mar 22; 159(6):619-24. PubMed ID: 10090119
    [Abstract] [Full Text] [Related]

  • 27. A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload.
    Tarng DC, Huang TP.
    Nephrol Dial Transplant; 1998 Nov 22; 13(11):2867-72. PubMed ID: 9829492
    [Abstract] [Full Text] [Related]

  • 28. Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: influence of serum ferritin levels.
    Chen WT, Lin YF, Yu FC, Kao WY, Huang WH, Yan HC.
    Am J Kidney Dis; 2003 Jul 22; 42(1):158-66. PubMed ID: 12830468
    [Abstract] [Full Text] [Related]

  • 29. The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C.
    Eiselt J, Racek J, Opatrný K, Trefil L, Stehlík P.
    Blood Purif; 2006 Jul 22; 24(5-6):531-7. PubMed ID: 17077626
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr 22; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 32. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
    Shahbazian H, Zand Moghadam A, Ehsanpour A, Khazaali M.
    Iran J Kidney Dis; 2009 Jul 22; 3(3):151-5. PubMed ID: 19617664
    [Abstract] [Full Text] [Related]

  • 33. Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria.
    Ogawa Y, Machida N, Ogawa T, Oda M, Hokama S, Chinen Y, Uchida A, Morozumi M, Sugaya K, Motoyoshi Y, Hattori M.
    Urol Res; 2006 Feb 22; 34(1):12-6. PubMed ID: 16432691
    [Abstract] [Full Text] [Related]

  • 34. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.
    Cetin O, Bekpinar S, Unlucerci Y, Turkmen A, Bayram C, Ulutin T.
    Clin Nephrol; 2006 Feb 22; 65(2):97-102. PubMed ID: 16509458
    [Abstract] [Full Text] [Related]

  • 35. Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients.
    Balcke P, Schmidt P, Zazgornik J, Kopsa H, Deutsch E.
    Eur J Clin Invest; 1982 Dec 22; 12(6):481-3. PubMed ID: 6818036
    [Abstract] [Full Text] [Related]

  • 36. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients.
    Obeid R, Kuhlmann MK, Köhler H, Herrmann W.
    Clin Chem; 2005 Jan 22; 51(1):196-201. PubMed ID: 15528294
    [Abstract] [Full Text] [Related]

  • 37. Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunction.
    McIntyre CW, Fluck RJ, Freeman JG, Lambie SH.
    Clin Nephrol; 2002 Nov 22; 58(5):376-83. PubMed ID: 12425489
    [Abstract] [Full Text] [Related]

  • 38. Plasma oxalate levels in prevalent hemodialysis patients and potential implications for ascorbic acid supplementation.
    Liu Y, Weisberg LS, Langman CB, Logan A, Hunter K, Prasad D, Avila J, Venkatchalam T, Berns JS, Handelman GJ, Sirover WD.
    Clin Biochem; 2016 Oct 22; 49(15):1133-1139. PubMed ID: 27265723
    [Abstract] [Full Text] [Related]

  • 39. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis.
    McConnell KN, Rolton HA, Modi KS, Macdougall AI.
    Am J Kidney Dis; 1991 Oct 22; 18(4):441-5. PubMed ID: 1928062
    [Abstract] [Full Text] [Related]

  • 40. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 22; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.